Gottlieb Talks Activist Role For FDA In Curbing REMS Abuse
Executive Summary
US FDA commissioner says he would be happy to work with Congress on a legislative solution on the issue, but emphasized his priority is for the agency to develop a system itself to discourage REMS abuse.
You may also be interested in...
US FDA To Publish Own Datasets In Latest Signal Of Enhanced Transparency
Adverse event reporting data will also be more readily available, Commissioner Scott Gottlieb says.
Brands Push Back Against REMS Reform, Call Problem Small With Burdensome Fixes
BIO cautioned that its members may have difficulties meeting the purchase orders of product for generic sponsors, while PhRMA contended legislation is not necessary.
Brands Push Back Against REMS Reform, Call Problem Small With Burdensome Fixes
BIO cautioned that its members may have difficulties meeting the purchase orders of product for generic sponsors, while PhRMA contended legislation is not necessary.